Ronald G. Gelbman, Director at HAEMONETICS CORP (HAE), sold 8,658 shares at $103.02 ($892K) on 2018-12-14, disclosed to the SEC on 2018-12-18.
Open-market sale of $892k HAE by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $103.02 | 4,329 | $446K | 50.0% |
| 2 | $103.02 | 4,329 | $446K | 50.0% |
| Total | $103.02 avg | 8,658 | $892K | 100% |
| Filing → |
| HAE | SELL | 2019-02-19 | $1.4M | — | Filing → |
| HAE | SELL | 2017-11-17 | $331K | — | Filing → |
| HAE | SELL | 2017-04-27 | $343K | — | Filing → |